Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.
Start Over | Back to Search Results
Dextrose 5% Injection
Status: Currently in Shortage
»Date first posted:
02/14/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Other; Pediatric
B. Braun Medical Inc. (New 02/16/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
5% 500 mL Excel Bag L5101 (NDC 0264-7510-10) | Product on allocation for contracted customers | Other | |
5% 1000 mL Excel Bag L5100 (NDC 0264-7510-00) | Product on allocation for contracted customers | Other | |
5% 250 mL Excel Bag L5102 (NDC 0264-7510-20) | Product on allocation for contracted customers | Other | |
5% 100 mL PAB Bag S5104-5264 (NDC 0264-1510-32) | Product available | ||
5% 50 mL PAB Bag S5104-5364 (NDC 0264-1510-31) | Product available | ||
10% 1000 mL Excel Bag L5200 (NDC 0264-7520-00) | Product available | ||
10% 500 mL Excel Bag L5201 (NDC 0264-7520-10) | Product available | ||
10% 250 mL Excel Bag L5202 (NDC 0264-7520-20) | Product on allocation for contracted customers | Other |
Baxter Healthcare (Revised 07/01/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
5% Dextrose Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack, Product Code 2B0080, (NDC 0338-0017-10) | Available on allocation | ||
5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Product Code 2B0086, (NDC 0338-0017-41) | Available on allocation | ||
5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0081, (NDC 0338-0017-11) | Available on allocation | ||
5% Dextrose Injection, USP, 50 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0088, (NDC 0338-0017-31) | Available | ||
5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Product Code 2B0087, (NDC 0338-0017-48) | Available on allocation | ||
5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Quad Pack, Product Code 2B0082, (NDC 0338-0017-18) | Available on allocation. | ||
5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Multi Pack, Product Code 2B0089, (NDC 0338-0017-38) | Available on allocation | ||
5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container. Quad Pack, Product Code 2B0040, (NDC 0338-0551-11) | Available on allocation | ||
5% Dextrose Injection, USP, 50 mL MINI-BAG Plus Container, Product Code EZPB0040, (NDC 0338-9143-30) | Available on allocation | Demand increase | |
5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code EZPB0041, (NDC 0338-9147-30) | Limited supply on allocation; Recovery 2023 | ||
5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, Product Code 2B0041, (NDC 0338-0551-18) | Available on allocation | Demand increase | |
5% Dextrose Injection, USP, 1000 mL VIAFLO Plastic Container, Product Code UE0064D, (NDC 0338-0070-10) | Available on allocation | ||
5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container, Product Code 2B0062Q, (NDC 0338-0017-02) | Available on allocation | ||
5% Dextrose Injection, USP, 250 mL VIAFLO Plastic Container, Product Code UE0062D, (NDC 0338-0062-30) | Available on allocation | ||
5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container, Product Code 2B0063Q, (NDC 0338-0017-03) | Available on allocation | ||
5% Dextrose Injection, USP, 500 mL VIAFLO Plastic Container, Product Code UE0063D, (NDC 0338-0066-20) | Limited supply on allocation; Recovery July 2022 |
Fresenius Kabi USA, LLC (Revised 08/12/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (5 grams per 100 mL) (NDC 63323-624-61) | Backordered. Next release not available at this time. | Increase in Demand | |
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (12.5 grams per 250 mL) (NDC 63323-624-74) | Backordered. Next release September 2022. | Increase in Demand | |
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (25 grams per 500 mL) (NDC 63323-624-75) | Backordered. Next release August 2022. | Increase in Demand | |
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (50 grams per 1,000 mL) (NDC 63323-624-10) | Backordered. Next release September 2022. | Increase in Demand | |
5% Dextrose Injection, Single dose freeflex bag, (50 mg per mL), (2.5 grams per 50 mL) (NDC 63323-624-50) | Backordered. Next release not available at this time. | Increase in Demand |
Hospira, Inc., a Pfizer Company (Revised 07/01/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
50 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-66) | Next Delivery: July 2022; Estimated Recovery: August 2022 | Demand increase for the drug | |
100 mL; ADD-Vantage Flexible Container (Case of 50)(NDC 0409-7100-67) | Limited Supply Available. Next Delivery and Estimated Recovery: July 2022 | Other | |
250 mL; ADD-Vantage Flexible Container (Case of 24)(NDC 0409-7100-02) | Limited Supply Available. Next Delivery and Estimated Recovery: July 2022 | Other |
ICU Medical, Inc. (Reverified 08/12/2022)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
5% Dextrose Injection, USP, 250 mL (Legacy Hospira NDC 0409-7922-02) (ICU Medical NDC 0990-7922-02) | Available | Demand increase for the drug | |
5% Dextrose Injection, USP, 150 mL (Legacy Hospira NDC 0409-7922-61) (ICU Medical NDC 0990-7922-61) | Available | Demand increase for the drug | |
5% Dextrose Injection, USP, 50 mL (Legacy Hospira NDC 0409-7923-13) (ICU Medical NDC 0990-7923-13) | Allocation | Demand increase for the drug | |
5% Dextrose Injection, USP, 25 mL 4-1 (Legacy Hospira NDC 0409-7923-20) (ICU Medical NDC 0990-7923-20) | Available | Demand increase for the drug | |
5% Dextrose Injection, USP, 100 mL (Legacy Hospira NDC 0409-7923-23) (ICU Medical NDC 0990-7923-23) | Allocated to Contracted Customers Only | Demand increase for the drug | |
5% Dextrose Injection, USP, 50 mL 4-1 (Legacy Hospira NDC 0409-7923-36) (ICU Medical NDC 0990-7923-36) | Allocation | Demand increase for the drug | |
5% Dextrose Injection, USP, 100 mL 4-1 (Legacy Hospira NDC 0409-7923-37) (ICU Medical NDC 0990-7923-37) | Allocation | Demand increase for the drug | |
5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-03) (ICU Medical NDC 0990-7922-03) | Available | ||
5% Dextrose Injection, USP, 500 mL (Legacy Hospira NDC 0409-7922-55) (ICU Medical NDC 0990-7922-55) | Available | ||
5% Dextrose Injection, USP, 50 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-06) (ICU Medical NDC 0990-7923-06) | Available | ||
5% Dextrose Injection, USP, 100 mL VisIV™ Container (Legacy Hospira NDC 0409-7923-11) (ICU Medical NDC 0990-7923-11) | Available | ||
5% Dextrose Injection, USP, 250 mL VisIV™ Container (Legacy Hospira NDC 0409-7922-25) (ICU Medical NDC 0990-7922-25) | Available | ||
5% Dextrose Injection, USP, 1000 mL (Legacy Hospira NDC 0409-7922-09) (ICU Medical NDC 0990-7922-09) | Available |